Immunotherapy

Molecular underpinnings of exceptional response in primary malignant melanoma of the esophagus to anti-PD-1 monotherapy
Jie Dai, Xue Bai, Xuan Gao, Lirui Tang, Yu Chen, Linzi Sun, Xiaoting Wei, Caili Li, Zhonghui Qi, Yan Kong, Chuanliang Cui, Zhihong Chi, Xinan Sheng, Zelong Xu, Bin Lian, Siming Li, Xieqiao Yan, Bixia Tang, Li Zhou, Xuan Wang, Xuefeng Xia, Jun Guo, Lili Mao, Lu Si

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005937; DOI: 10.1136/jitc-2022-005937
Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer
Alok A Khorana, Jennell Palaia, Lisa Rosenblatt, Radhika Pisupati, Ning Huang, Chi Nguyen, John Barron, Kerrin Gallagher, T Christopher Bond

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006072; DOI: 10.1136/jitc-2022-006072
Spontaneous, naturally occurring cancers in non-human primates as a translational model for cancer immunotherapy
Simon Deycmar, Bruno Gomes, Jehad Charo, Maurizio Ceppi, J Mark Cline

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005514; DOI: 10.1136/jitc-2022-005514
Human soft tissue sarcomas harbor an intratumoral viral microbiome which is linked with natural killer cell infiltrate and prognosis
Lauren M Perry, Sylvia M Cruz, Kara T Kleber, Sean J Judge, Morgan A Darrow, Louis B Jones, Ugur N Basmaci, Nikhil Joshi, Matthew L Settles, Blythe P Durbin-Johnson, Alicia A Gingrich, Arta Monir Monjazeb, Janai Carr-Ascher, Steve W Thorpe, William J Murphy, Jonathan A Eisen, Robert J Canter

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e004285; DOI: 10.1136/jitc-2021-004285
Phase 1, open-label, dose-escalation study on the safety, pharmacokinetics, and preliminary efficacy of intravenous Coxsackievirus A21 (V937), with or without pembrolizumab, in patients with advanced solid tumors
Charles M Rudin, Hardev S Pandha, Matthew Zibelman, Wallace L Akerley, Kevin J Harrington, Daphne Day, Andrew G Hill, Steven J O'Day, Timothy D Clay, Gavin M Wright, Ross R Jennens, David E Gerber, Jonathan E Rosenberg, Christy Ralph, David C Campbell, Brendan D Curti, Jaime R Merchan, Yixin Ren, Emmett V Schmidt, Lisa Guttman, Sumati Gupta

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005007; DOI: 10.1136/jitc-2022-005007
STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
Liya Ding, Qiwei Wang, Antons Martincuks, Michael J Kearns, Tao Jiang, Ziying Lin, Xin Cheng, Changli Qian, Shaozhen Xie, Hye-Jung Kim, Inga-Maria Launonen, Anniina Färkkilä, Thomas M Roberts, Gordon J Freeman, Joyce F Liu, Panagiotis A Konstantinopoulos, Ursula Matulonis, Hua Yu, Jean J Zhao

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005627; DOI: 10.1136/jitc-2022-005627
Diabetes insipidus and Guillain-Barré-like syndrome following CAR-T cell therapy: a case report
Christian Koch, Juliane Fleischer, Todor Popov, Karl Frontzek, Bettina Schreiner, Patrick Roth, Markus G. Manz, Simone Unseld, Antonia M. S. Müller, Norman F. Russkamp

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006059; DOI: 10.1136/jitc-2022-006059
New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors
Aristotelis Bamias, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo de Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N Sternberg

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005977; DOI: 10.1136/jitc-2022-005977
TYRO3 blockade enhances anti-PD-1 therapy response by modulating expression of CCN1 in tumor microenvironment
Miso Park, Da-Sol Kuen, Jaewoo Park, Munkyung Choi, Yeonji Kim, Eun Chae Roh, Yong June Choi, Yoon Gyoon Kim, Yeonseok Chung, Sung Yun Cho, Keon Wook Kang

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e006084; DOI: 10.1136/jitc-2022-006084
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma
Ming Sun, Yingying Cao, Reona Okada, Jeyshka M Reyes-González, Hannah G Stack, Haiying Qin, Nan Li, Charlie Seibert, Michael C Kelly, Eytan Ruppin, Mitchell Ho, Carol J Thiele, Rosa Nguyen

Journal for ImmunoTherapy of Cancer Jan 2023, 11 (1) e005881; DOI: 10.1136/jitc-2022-005881

Main menu

Immunotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Immunotherapy

Pages